Patents Assigned to APELLIS AG
  • MODULATION AND REPLETION/ENHANCEMENT OF THE COMPLEMENT SYSTEM FOR TREATMENT OF TRAUMA
    Publication number: 20110190221
    Abstract: The present invention features the use of selected complement activation inhibitor(s) for treating an individual who has suffered a severe injury. The complement activation inhibitor acts at or above the level of C3 activation and does not significantly deplete or irreversibly inhibit complement activation. Also provided are compositions and methods for repleting and/or enhancing complement activation capacity in a subject who has suffered a traumatic injury.
    Type: Application
    Filed: March 30, 2009
    Publication date: August 4, 2011
    Applicant: APELLIS AG
    Inventors: Cedric Francois, Pascal Deschatelets, Paul Olson